* Penederm Inc., of Foster City, Calif., said it has received approval inCanada to market three new concentrations of Vitinoin, a prescriptionretinoic acid topical cream for acne. The company already was grantedCanadian approval of its acne gel form of Vitinoin. Penederm's newdrug applications of Vitinoin are under review by the FDA in the U.S.* ID Biomedical Corp., a Vancouver, Canada-based companydeveloping DNA diagnostic products, is listing its common shares onThe Montreal Exchange. The company's symbol is IDB and inpublished stock quotes it will be listed as ID Bio.

(c) 1997 American Health Consultants. All rights reserved.

No Comments